Unknown

Dataset Information

0

CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas.


ABSTRACT: Mutations of CCM3/PDCD10 cause 10-15% of hereditary cerebral cavernous malformations. The phenotypic characterization of CCM3-mutated patients has been hampered by the limited number of patients harboring a mutation in this gene. This is the first report on molecular and clinical features of a large cohort of CCM3 patients. Molecular screening for point mutations and deletions was used to identify 54 CCM3-mutated index patients. Age at referral and clinical onset, type of inaugural events and presence of extra-axial lesions were investigated in these 54 index patients and 22 of their mutated relatives. Mean age at clinical onset was 23.0 ± 16 years. Clinical onset occurred before 10 years in 26% of the patients, and cerebral hemorrhage was the initial presentation in 72% of these patients. Multiple extra-axial, dural-based lesions were detected in 7 unrelated patients. These lesions proved to be meningiomas in 3 patients who underwent neurosurgery and pathological examination. This 'multiple meningiomas' phenotype is not associated with a specific CCM3 mutation. Hence, CCM3 mutations are associated with a high risk of early-onset cerebral hemorrhage and with the presence of multiple meningiomas.

SUBMITTER: Riant F 

PROVIDER: S-EPMC3666455 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas.

Riant F F   Bergametti F F   Fournier H-D HD   Chapon F F   Michalak-Provost S S   Cecillon M M   Lejeune P P   Hosseini H H   Choe C C   Orth M M   Bernreuther C C   Boulday G G   Denier C C   Labauge P P   Tournier-Lasserve E E  

Molecular syndromology 20130403 4


Mutations of CCM3/PDCD10 cause 10-15% of hereditary cerebral cavernous malformations. The phenotypic characterization of CCM3-mutated patients has been hampered by the limited number of patients harboring a mutation in this gene. This is the first report on molecular and clinical features of a large cohort of CCM3 patients. Molecular screening for point mutations and deletions was used to identify 54 CCM3-mutated index patients. Age at referral and clinical onset, type of inaugural events and pr  ...[more]

Similar Datasets

| S-EPMC1955825 | biostudies-other
| S-EPMC3943187 | biostudies-literature
| S-EPMC4193683 | biostudies-literature
| S-EPMC5074729 | biostudies-literature
| S-EPMC3335762 | biostudies-literature
| S-EPMC3624967 | biostudies-literature
| S-EPMC3527897 | biostudies-literature
| S-EPMC5607553 | biostudies-literature
| S-EPMC4764606 | biostudies-literature
| S-EPMC4618087 | biostudies-literature